Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies

CD38 was first discovered as a T-cell antigen and has since been found ubiquitously expressed in various hematopoietic cells, including plasma cells, NK cells, B cells, and granulocytes. More importantly, CD38 expression levels on malignant hematopoietic cells are significantly higher than counterpa...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, Nurulhuda, Azaman, Muhamad Irfan, Ng, Giselle G. K., Chng, Wee Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496523/
https://www.ncbi.nlm.nih.gov/pubmed/36139103
http://dx.doi.org/10.3390/biom12091261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496523/
https://www.ncbi.nlm.nih.gov/pubmed/36139103
http://dx.doi.org/10.3390/biom12091261

Ejemplares similares